OTTMUSG00000005288 Inhibitors
Chemical inhibitors of Gm12063 are selected based on their potential to interfere with key cellular processes that might be relevant to the function of this uncharacterized protein. These inhibitors target various signaling molecules and pathways within the cell, which could indirectly impact the function or regulation of Gm12063. The inhibitors, including Staurosporine, Rapamycin, LY294002, Wortmannin, U0126, PD98059, SB203580, SP600125, LY3214996, AZD6244, BMS-354825, and Trametinib, are chosen for their actions on protein kinases, mTOR, PI3K, MEK, and MAPK pathways. These pathways play critical roles in cell growth, proliferation, and signal transduction, and their inhibition could affect a variety of proteins.
For Gm12063, the disruption of these pathways might lead to a functional impact, either directly affecting its activity or altering the cellular environment and signaling contexts in which it operates. While the specific functions and pathway involvements of Gm12063 are not known, targeting these fundamental cellular processes provides a logical strategy to identify potential inhibitors. The assumption is that Gm12063, like many proteins, could be involved in or regulated by these key cellular pathways. Therefore, inhibiting these pathways offers a potential approach to functionally inhibit Gm12063 within a cellular context.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits a broad spectrum of protein kinases, potentially affecting the phosphorylation status of Gm12063, which could be vital for its functional activity or stability. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin targets mTOR, a central regulator of cell growth and proliferation. Inhibition of mTOR might impact cellular conditions essential for Gm12063's functional expression or activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, disrupting PI3K-dependent signaling pathways that could be involved in regulating or mediating the activity of Gm12063. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, might similarly alter PI3K-related pathways, affecting processes or signaling routes in which Gm12063 could be involved. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, inhibiting MEK1/2, impacts the MAPK/ERK pathway, which is implicated in various cellular processes, potentially including those regulated by Gm12063. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, could disrupt the MAPK/ERK pathway, thereby potentially influencing processes where Gm12063 is involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 targets p38 MAP kinase, potentially affecting signaling pathways and cellular processes relevant to Gm12063's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which could impact signaling pathways and processes where Gm12063 might play a role. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $265.00 | ||
LY3214996, an ERK1/2 inhibitor, might affect the ERK pathway, potentially impacting Gm12063's function or regulation. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib, a MEK inhibitor, could disrupt the MAPK/ERK pathway, potentially influencing Gm12063's role in cellular processes. | ||||||